SCHEMBL4622260

SCHEMBL4622260

N#Cc1ccc([AsH]c2cc(N3CCOCC3)nc(-c3cccc(O)c3)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 17/20 0.55
PIK3CG P48736 8/20 0.55
PIK3CB P42338 5/20 0.55
PIK3CD O00329 4/20 0.53
HTT P42858 1/20 0.46
MTOR P42345 7/20 0.44
PIK3C2B O00750 1/20 0.43
CCNE2 O96020 1/20 0.43
PRKACA P17612 1/20 0.43
PRKACG P22612 1/20 0.43
PRKACB P22694 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
KDR P35968 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HDAC8 Q9BY41 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4147474 0.81 ABCG2 (0.60) PIK3CAPIK3CGPIK3CBPIK3CD
SCHEMBL4140239 0.77 PIK3CA (0.55) PIK3CAPIK3CGPIK3CBPIK3CDMTOR
SCHEMBL4139135 0.74 PIK3CA (0.74) PIK3CAPIK3CGPIK3CBPIK3CDHTT
SCHEMBL15299524 0.71 PIK3CA (1.00) PIK3CAPIK3CGPIK3CBPIK3CDHTT
SCHEMBL4138246 0.71 PIK3CA (0.67) PIK3CAPIK3CGPIK3CBPIK3CDHTT
SCHEMBL1311387 0.71 PIK3CA (0.69) PIK3CAPIK3CGPIK3CBPIK3CDHTT
SCHEMBL5172881 0.70 PIK3CA (1.00) PIK3CAPIK3CGPIK3CBPIK3CDHTT
SCHEMBL28871764 0.70 PIK3CA (0.55) PIK3CAPIK3CGPIK3CBPIK3CDMTOR
SCHEMBL1311669 0.70 PIK3CA (0.82) PIK3CAPIK3CGPIK3CBPIK3CDMTOR
SCHEMBL4138270 0.69 ALDH1A1 (0.69) PIK3CAPIK3CGPIK3CBPIK3CDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945627-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCER LUDWIG INSTITUTE FOR CANCER RESEARCH (CH) 2008-07-23 EP disclosed
WO-2007042806-A1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF CANCER LUDWIG INSTITUTE FOR CANCER RESEARCH (CH) 2007-04-19 WO disclosed